AGL Quote, Financials, Valuation and Earnings

Astrana Health, Inc. has a net margin of -7.68% compared to Agilon Health, Inc.'s net margin of 0.11%. Agilon Health, Inc.'s return on equity of -71.4% beat Astrana Health, Inc.'s return on equity of 1.85%.

Agilon Health, Inc. has a consensus price target of $0.99, signalling downside risk potential of -0.52%. On the other hand Astrana Health, Inc. has an analysts' consensus of $36.8889 which suggests that it could grow by 35.82%. Given that Astrana Health, Inc. has higher upside potential than Agilon Health, Inc., analysts believe Astrana Health, Inc. is more attractive than Agilon Health, Inc..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Astrana Health, Inc. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.424%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Astrana Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. Astrana Health, Inc. pays out -- of its earnings as a dividend.

Agilon Health, Inc. quarterly revenues are $1.4B, which are larger than Astrana Health, Inc. quarterly revenues of $956M. Agilon Health, Inc.'s net income of -$110.2M is lower than Astrana Health, Inc.'s net income of $1.1M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while Astrana Health, Inc.'s PE ratio is 142.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.07x versus 0.46x for Astrana Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

InnovAge Holding Corp. has a net margin of -7.68% compared to Agilon Health, Inc.'s net margin of 3.25%. Agilon Health, Inc.'s return on equity of -71.4% beat InnovAge Holding Corp.'s return on equity of -7.99%.

Agilon Health, Inc. has a consensus price target of $0.99, signalling downside risk potential of -0.52%. On the other hand InnovAge Holding Corp. has an analysts' consensus of $5.00 which suggests that it could fall by -14.24%. Given that InnovAge Holding Corp. has more downside risk than Agilon Health, Inc., analysts believe Agilon Health, Inc. is more attractive than InnovAge Holding Corp..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InnovAge Holding Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InnovAge Holding Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. InnovAge Holding Corp. pays out -- of its earnings as a dividend.

Agilon Health, Inc. quarterly revenues are $1.4B, which are larger than InnovAge Holding Corp. quarterly revenues of $236.1M. Agilon Health, Inc.'s net income of -$110.2M is lower than InnovAge Holding Corp.'s net income of $7.7M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while InnovAge Holding Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.07x versus 0.89x for InnovAge Holding Corp.. Usually stocks with elevated PS ratios are considered overvalued.

National HealthCare Corp. has a net margin of -7.68% compared to Agilon Health, Inc.'s net margin of 10.77%. Agilon Health, Inc.'s return on equity of -71.4% beat National HealthCare Corp.'s return on equity of 10.22%.

Agilon Health, Inc. has a consensus price target of $0.99, signalling downside risk potential of -0.52%. On the other hand National HealthCare Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Agilon Health, Inc. has higher upside potential than National HealthCare Corp., analysts believe Agilon Health, Inc. is more attractive than National HealthCare Corp..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National HealthCare Corp. has a beta of 0.645, suggesting its less volatile than the S&P 500 by 35.519%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National HealthCare Corp. offers a yield of 1.77% to investors and pays a quarterly dividend of $0.64 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. National HealthCare Corp. pays out 37.04% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilon Health, Inc. quarterly revenues are $1.4B, which are larger than National HealthCare Corp. quarterly revenues of $380.8M. Agilon Health, Inc.'s net income of -$110.2M is lower than National HealthCare Corp.'s net income of $41M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while National HealthCare Corp.'s PE ratio is 22.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.07x versus 1.50x for National HealthCare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sonida Senior Living, Inc. has a net margin of -7.68% compared to Agilon Health, Inc.'s net margin of -27.9%. Agilon Health, Inc.'s return on equity of -71.4% beat Sonida Senior Living, Inc.'s return on equity of -41.74%.

Agilon Health, Inc. has a consensus price target of $0.99, signalling downside risk potential of -0.52%. On the other hand Sonida Senior Living, Inc. has an analysts' consensus of $31.50 which suggests that it could fall by -0.13%. Given that Agilon Health, Inc. has more downside risk than Sonida Senior Living, Inc., analysts believe Sonida Senior Living, Inc. is more attractive than Agilon Health, Inc..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonida Senior Living, Inc. has a beta of 0.620, suggesting its less volatile than the S&P 500 by 38.032%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonida Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. Sonida Senior Living, Inc. pays out 85.92% of its earnings as a dividend. Sonida Senior Living, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilon Health, Inc. quarterly revenues are $1.4B, which are larger than Sonida Senior Living, Inc. quarterly revenues of $98M. Agilon Health, Inc.'s net income of -$110.2M is lower than Sonida Senior Living, Inc.'s net income of -$27.3M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while Sonida Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.07x versus 1.54x for Sonida Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.